0.5746USD-3.53%Mkt Cap: 12.16M USDP/E: —Last update: 2026-06-01
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-a…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap12.16M USD
Enterprise Value9.72M USD
Revenue (TTM)275.58K USD
Gross Profit240.27K USD
Net Income (TTM)-8.22M USD
Revenue/Share0.0150 USD
Last Price0.5746 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees8
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.97
PEG—
EV/EBITDA-1.15
EV/Revenue35.27
P/S47.68
P/B4.36
EPS (TTM)-0.46
EPS (Forward)-0.31
52W Range
0.305016% of range2.000
52W High2.000 USD
52W Low0.3050 USD
Profitability
Gross Margin79.65%
Oper. Margin-14179.95%
EBITDA Margin0.00%
Profit Margin-2725.76%
ROE-219.38%
ROA-177.38%
Growth
Revenue Growth-63.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.96M USD
CapEx (TTM)96.86K USD
FCF Margin-759.28%
FCF Yield-17.21%
Net Debt-2.71M USD
Net Debt/EBITDA0.32
Balance Sheet
Debt/Equity—
Current Ratio4.07
Quick Ratio3.40
Book Value/Sh0.1400 USD
Cash/Share0.1320 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.0 (Buy)
Target (Mean)2.000 USD
Target Range2.000 USD – 2.000 USD
# Analysts1
Ownership
Shares Out.21.54M
Float17.86M
Insiders11.23%
Institutions5.18%
Short Interest
Short Ratio3.5d
Short % Float2.97%
Short % Out.2.82%
Shares Short607.38K
Short (prev mo.)601.12K
Technical
SMA 500.3941 (+45.8%)
SMA 2000.7491 (-23.3%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)888.14K
Avg Vol (10d)2.52M
Technical Indicators
RSI (14)76.4
MACD0.0379
MACD Signal0.0063
MACD Hist.+0.0316
BB Upper0.5700 USD
BB Middle0.3929 USD
BB Lower0.2158 USD
BB Width90.16%
ATR (14)0.0577 USD
Vol Ratio (20d)0.20x